Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B-Reference-Cited by-同舟云学术

Long-term lamivudine treatment achieves regression of advanced liver fibrosis/cirrhosis in patients with chronic hepatitis B

Author:

Xu Bei¹,Lin Lanyi¹,Xu Guoguang²,Zhuang Yan¹,Guo Qing¹,Liu Yunye¹,Wang Hui¹,Zhou Xiaqiu¹,Wu Shanming²,Bao Shisan³,Cai Wei¹,Xie Qing¹

Affiliation:

1. Department of Infectious Diseases; Ruijin Hospital; Shanghai Jiao Tong University School of Medicine; Shanghai China

2. Department of Liver Diseases; Shanghai Public Health Clinical Center; Fudan University; Shanghai China

3. Discipline of Pathology; School of Medical Sciences and Bosch Institute; University of Sydney; Sydney New South Wales Australia

Funder

GSK

National Key Programs on Infectious Diseases of China

National Science and Technology Major Project of China

Shanghai Science and Technology Committee

National Clinical Key Speciality Construction Project of China

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

Reference26 articles.

1. Chronic hepatitis B;Lok;Hepatology,2007

2. Hepatitis B virus infection;Lee;N. Engl. J. Med.,1997

5. Viral hepatitis C;Poynard;Lancet,2003

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献